Mednet Logo
HomeDermatologyQuestion

How do you counsel patients who inquire about benzene exposure and carcinogenic risk from BPO containing acne and rosacea products?

1 Answers
Mednet Member
Mednet Member
Dermatology · Stanford University

This question is easier to answer after this recent report from the FDA:

Limited number of voluntary recalls initiated after FDA testing of acne products for benzene; findings show a small number of products with elevated levels of benzene contamination

It supports the overall safety of BP.

More t...

Register or Sign In to see full answer

How do you counsel patients who inquire about benzene exposure and carcinogenic risk from BPO containing acne and rosacea products? | Mednet